Antiviral Drug-Resistance Typing Reveals Compartmentalization and Dynamics of Acyclovir-Resistant Herpes Simplex Virus Type-2 (HSV-2) in a Case of Neonatal Herpes
Author(s) -
Ma Bache,
Graciela Andreï,
L. Bindl,
Leon Bofferding,
Jean Bottu,
Christine Geron,
Claudia Neuhauser,
Sarah Gillemot,
Pierre Fiten,
Ghislain Opdenakker,
Robert Snoeck
Publication year - 2013
Publication title -
journal of the pediatric infectious diseases society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.269
H-Index - 31
eISSN - 2048-7207
pISSN - 2048-7193
DOI - 10.1093/jpids/pit045
Subject(s) - herpes simplex virus , medicine , virology , cerebrospinal fluid , hsl and hsv , virus , drug resistance , aciclovir , herpesviridae , immunology , viral disease , pathology , biology , microbiology and biotechnology
A neonate suffering from herpes simplex virus type 2 disease with central nervous system involvement developed an early recurrence under acyclovir therapy. Isolates from the cerebrospinal fluid and skin lesions were acyclovir resistant, while viruses from blood and trachea were not. Acyclovir combined with foscavir followed by long-term suppressive acyclovir therapy supported normal neurological development.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom